-transparent.png){kind=logo}
We have investigated the possible interaction of Japanese Kampo medicine; Shosaiko-to with Epstein-Barr virus (EBV) induction by TPA (12-O-tetra-decanoyl-phorbol-13-acetate) in EBV-genome harboring cells. The effect of ether extract of Shosaiko-to was also studied on the induction of EBV by superinfection with EBV from P3HR-1 cells (P3H-EBV). Concomitant treatment of EBV-latently-infected cells (Raji and A2L/AH) with TPA and ether extract resulted in effective inhibition of EBV-antigen induction. However, in the experiments to test the influence of ether extract on EBV induction by superinfecting Raji cells with P3H-EBV, ether extract did not affect the percentage of EBV-antigen-positive cells. These data indicate that Shosaiko-to is effective to inhibit antigen synthesis induced by chemical promoters without affecting EBV-antigen induction after superinfection.
M Furukawa, and
H Sakashita, and
M Kamide, and
R Umeda
January 1993,
Cancer letters,
M Furukawa, and
H Sakashita, and
M Kamide, and
R Umeda
August 1991,
Cancer letters,
M Furukawa, and
H Sakashita, and
M Kamide, and
R Umeda
February 1987,
Nihon Jibiinkoka Gakkai kaiho,
M Furukawa, and
H Sakashita, and
M Kamide, and
R Umeda
December 1997,
Cancer letters,
M Furukawa, and
H Sakashita, and
M Kamide, and
R Umeda
August 1981,
International journal of cancer,
M Furukawa, and
H Sakashita, and
M Kamide, and
R Umeda
April 1997,
Chemical & pharmaceutical bulletin,
M Furukawa, and
H Sakashita, and
M Kamide, and
R Umeda
May 2003,
Journal of agricultural and food chemistry,
M Furukawa, and
H Sakashita, and
M Kamide, and
R Umeda
March 1984,
Cancer research,
M Furukawa, and
H Sakashita, and
M Kamide, and
R Umeda
August 1995,
Cancer letters,
M Furukawa, and
H Sakashita, and
M Kamide, and
R Umeda
February 2003,
Bioorganic & medicinal chemistry,
